CREDIT SUISSE AG/ - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$12,000
+20.0%
22,000
-17.0%
0.00%
Q1 2018$10,000
-52.4%
26,500
+32.5%
0.00%
Q4 2017$21,000
-40.0%
20,000
-33.3%
0.00%
Q3 2017$35,00030,0000.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,616,000$1,891,0000.22%
SABBY MANAGEMENT, LLC 46,378$54,0000.00%
TWO SIGMA SECURITIES, LLC 32,022$37,0000.00%
Vantage Investment Advisors, LLC 6,500$8,0000.00%
IFP Advisors, Inc 25,800$30,0000.00%
Virtu Financial LLC 15,967$19,0000.00%
BANK OF AMERICA CORP /DE/ 524$1,0000.00%
WELLS FARGO & COMPANY/MN 100$00.00%
NORTHERN TRUST CORP 11,277$13,0000.00%
CREDIT SUISSE AG/ 30,000$35,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders